Opioid Addiction Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2033

Reasons to buy the ‘Opioid Addiction Market’ opportunity assessment report:

The report offers:

• A detailed overview of opioid addiction, inclusive opioid use disorder (OUD), and opioid withdrawal syndrome (OWS), including epidemiology, symptoms, diagnosis, and disease management.
• Annualized opioid addiction therapeutics market revenue, cost of therapy per patient, and treatment usage patterns forecast from 2023 to 2033.
• Pipeline analysis: comprehensive data assessing emerging trends and mechanisms of action under development for opioid addiction. The most promising candidates in late-stage development are profiled.
• Key topics covered include strategic competitor assessment, market characterization, unmet needs, clinical trial mapping, and implications of these factors for the opioid addiction market.
• Analysis of the current and future market competition in the 8MM opioid addiction therapeutics market. Insightful review of the key industry drivers, restraints, and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.

How is our ‘Opioid Addiction Market’ report unique from other reports in the market?

• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving the 8MM opioid addiction therapeutics market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the opioid addiction therapeutics market in the future.

We recommend this valuable source of information to anyone involved in:

• Pharma and Biotech Companies – CNS Drug Manufacturers and Suppliers
• Consulting and Professional Services (e.g., Investment Companies, Investment Banks, Equity Companies, etc.)
• Pharmaceutical Industry Suppliers/Pharma Manufacturers (Innovative, Biotech, Generics, Biosimilars, Rare/Orphan Disease)/Distributors
• Financial Institutions (Investors in Pharma/Biotech, Pricing Consultancies)/Parallel Trade Organisations
• Healthcare Organisations/Healthcare Technology Leaders and Start-ups

To Get a Snapshot of the Opioid Addiction Market Report

Download a Free Sample Report

Opioid Addiction Market Report Overview

The opioid addiction market across the 8MM (the US, Canada, France, Germany, Italy, Spain, the UK, and Australia) was valued at $2 billion in 2023 and the market will grow at a CAGR of more than 1% from 2023 to 2033. The launch of four novel pipeline agents including Cannabidiol, Mazindol CR, Probenecid, and TRV‐734 will drive market growth over the forecast period.

Opioid Addiction Market Outlook 2023-2033 ($ Billion)
Buy the Full Report to Know More About the Opioid Addiction Market Forecast
Download a Free Sample Report

The opioid addiction market research report offers an overview of epidemiology, symptoms, diagnosis, and disease management. The report covers key topics, including strategic competitor assessment and market characterization that will help in identifying opioid addiction business strategies for opioid addiction market participants. In addition, the report’s data on unmet needs and clinical trial mapping will assist in understanding market gaps and making actionable predictions.

Opioid Addiction Market Dynamics

The opioid addiction market is dominated by two main opioid agonist therapies including methadone and buprenorphine. These are widely available in cheap generic forms, which will continue to dominate the market throughout the forecast period, limiting the uptake of more expensive branded products. However, Cannabidiol, Mazindol CR, Probenecid, and TRV‐734 are anticipated to launch across all the 8MM during the forecast period. Cannabidiol and Mazindol CR are expected to be used as potential adjunctive treatments and the standard of care thereby driving an increase in the OUD market.

Buy the Full Report for Additional Insights on the Key Opioid Addiction Market Dynamics
Download a Free Sample Report

Opioid Addiction Market Segmentation by Country

The key countries in the opioid addiction market are the US, Canada, France, Germany, Italy, Spain, the UK, and Australia. In 2023, the United States accounted for the highest share of the total opioid addiction market. The country’s growth is attributed to the larger OUD population, higher drug prices, and wider, and availability of opioid therapies.

Opioid Addiction Market Analysis by Country, 2023 (%)
Buy the Full Report for Country-Wise Insights on the Opioid Addiction Market
Download a Free Sample Report

Opioid Addiction Market Segmentation by Drug Classes

The key drug classes in the opioid addiction market are synthetic opioid analgesics, opioid receptor antagonist, dual synthetic opioid analgesicalpha 2a adrenergic receptor agonist (adra2a), and pipeline. In 2023, the synthetic opioid analgesics drug class sales were the highest in the opioid addiction market.

Opioid Addiction Market Analysis by Drug Classes, 2023 (%)
Buy the Full Report for Drug-Class Insights on the Opioid Addiction Market

Download a Free Sample Report

Segments Covered in this Report

Opioid Addiction Market Country Outlook ($ Billion, 2023-2033)

• The United States
• Canada
• France
• Germany
• Italy
• Spain
• The United Kingdom
• Australia

Opioid Addiction Market Drug Classes Outlook (%, 2023-2033)

• Synthetic Opioid Analgesics
• Opioid Receptor Antagonist
• Dual Synthetic Opioid Analgesic
• Alpha 2A Adrenergic Receptor Agonist (ADRA2A)
• Pipeline